GEDi Cube, an AI/ML platform that combines differential molecular capabilities with multi-omic analysis to detect cancer at its earliest stage, is delighted to announce the appointment of Craig Rhodes as Chief Executive Officer as the company enters the commercialisation phase. Craig brings over two decades’ experience in the healthcare and life sciences sector, with a primary focus on digital innovation. He has directed go-to-market strategies for solutions from disciplines ranging from genomic sequencing and drug discovery to medical imaging and research and he has worked with both public and private healthcare organisations to improve patient outcomes and experience. GEDi Cube offers a proprietary tool that analyses genetics using explainable AI (XAI) to provide early and accurate cancer diagnosis.
Add to Favourites
To login click here